首页> 外文期刊>Journal of chromatography, B. Analytical technologies in the biomedical and life sciences >Simultaneous determination of andrographolide, dehydroandrographolide and neoandrographolide in dog plasma by LC-MS/MS and its application to a dog pharmacokinetic study of Andrographis paniculata tablet
【24h】

Simultaneous determination of andrographolide, dehydroandrographolide and neoandrographolide in dog plasma by LC-MS/MS and its application to a dog pharmacokinetic study of Andrographis paniculata tablet

机译:LC-MS / MS同时测定狗血浆中穿心莲内酯,脱水穿心莲内酯和新穿心莲内酯的含量及其在穿心莲片中狗药代动力学研究中的应用

获取原文
获取原文并翻译 | 示例
           

摘要

In this study, a sensitive and rapid liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was developed and validated to simultaneously determinate andrographolide (AP), dehydroandrographolide (DP), and neoandrographolide (NP) in plasma of beagle dogs after oral administration of Andrographis paniculata tablet (A. paniculata). The analytes and bilobalide (internal standard) were separated on an Agilent ZORBAX XDB-C-18 column (50 mm x 2.1 mm, 3.5 mu m) by using gradient elution consisting of methanol and water at a flow rate of 0.50 mL/min in 7 min. Multiple reaction monitoring (MRM) mode was performed to quantify data under monitoring precursor-product ion transitions of m/z 348.8 --> 286.9, 330.9 --> 107.9,479.1 --> 160.8 and 325.0 --> 163.0 for AP, DP, NP and internal standard (IS) at negative ion mode, respectively. This method was developed at linearity ranging from 0.50 to 250 ng/mL for AP, 1.00 to 500 ng/mL for DP and 0.20 to 100 ng/mL for NP. The accuracy of each analyte ranged between 94.8% and 107.1% and the precision was within 14.6%. No significant matrix effect was observed. AP, DP and NP were stable during sample storage, preparation and analytic procedures. Furthermore, this method was successfully applied in the investigation of the pharmacokinetic profile of AP, DP and NP in beagle dogs after oral administration of Andrographis paniculata tablet (49.5 mg for AP, 7.0 mg for DP, 22.0 mg for NP). Biological half-life (t(1/2)) was 2.08 +/- 0.99, 3.13 +/- 1.19 and 1.07 +/- 0.38 h for AP, DP and NP, respectively. The areas under curves (AUC(0-t)) of AP, DP and NP was 494.50 +/- 150.64, 26.01 +/- 8.72 and 78.78 +/- 18.29 ng h/mL, respectively. (C) 2015 Elsevier B.V. All rights reserved.
机译:在这项研究中,开发了一种灵敏快速的液相色谱-串联质谱(LC-MS / MS)方法,并验证了该方法可同时测定比格犬血浆中的穿心莲内酯(AP),脱氢穿心莲内酯(DP)和新穿心莲内酯(NP)。穿心莲片(A. paniculata)口服。使用安捷伦ZORBAX XDB-C-18色谱柱(50 mm x 2.1 mm,3.5μm)在甲醇和水组成的梯度洗脱液中以0.50 mL / min的流速进行分离,分离出分析物和胆碱(内标) 7分钟在AP,DP的m / z监测前体-产物离子转变为m / z 348.8-> 286.9、330.9-> 107.9、479.1-> 160.8和325.0-> 163.0的情况下,执行多反应监测(MRM)模式以量化数据,NP和内标(IS)分别处于负离子模式。该方法的线性范围是:对于AP为0.50至250 ng / mL,对于DP为1.00至500 ng / mL,对于NP为0.20至100 ng / mL。每种分析物的准确度在94.8%和107.1%之间,准确度在14.6%以内。没有观察到明显的基质效应。在样品存储,制备和分析过程中,AP,DP和NP稳定。此外,该方法已成功应用于调查穿心莲片(AP为49.5 mg,DP为7.0 mg,NP为22.0 mg)比格犬中AP,DP和NP的药代动力学概况。 AP,DP和NP的生物半衰期(t(1/2))分别为2.08 +/- 0.99、3.13 +/- 1.19和1.07 +/- 0.38 h。 AP,DP和NP的曲线下面积(AUC(0-t))分别为494.50 +/- 150.64、26.01 +/- 8.72和78.78 +/- 18.29 ng h / mL。 (C)2015 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号